MPWT
VERA icon

MassMutual Private Wealth & Trust’s Vera Therapeutics VERA Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3
Closed -$121 – 2501
2026
Q1 		$121 Buy
+3
New +$129 ﹤0.01% 2350

Other funds holding VERA

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

MassMutual Private Wealth & Trust's VERA Position: Q2 2026 in Review

MassMutual Private Wealth & Trust sold out of Vera Therapeutics (VERA) in Q2 2026, closing a stake of 3 shares — an estimated $121 sold.

MassMutual Private Wealth & Trust first reported a position in VERA in Q1 2026 and held it in 1 quarter. The position peaked at $121 in Q1 2026. 37 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • MassMutual Private Wealth & Trust reported no remaining Vera Therapeutics position as of Q2 2026 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 3 Vera Therapeutics shares in Q2 2026, an estimated $121.
  • MassMutual Private Wealth & Trust first reported a position in Vera Therapeutics in Q1 2026 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Vera Therapeutics position peaked at $121 in Q1 2026.
  • 37 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.